Literature DB >> 25578870

The FIGO assessment scoring system (FASS): a new holistic classification tool to assess women with pelvic floor dysfunction: validity and reliability.

G Alessandro Digesu1, Steven Swift, Federica Puccini, Jittima Manonai, Vik Khullar, Ruwan Fernando, Oscar Contreras Ortiz, Stefano Salvatore.   

Abstract

INTRODUCTION AND HYPOTHESIS: The aim of our study was to assess the interobserver and intraobserver reliability as well as the content and construct validity of the FIGO prolapse assessment scoring system (FASS).
METHODS: Women with and without (controls) symptoms of pelvic organ prolapse (POP) attending gynaecology outpatient clinics in four different countries were recruited prospectively. Each woman was assessed using the FASS which included: (1) physical examination findings designated with the letter P; (2) presence of symptoms of prolapse, urinary and bowel symptoms designated with the letter S; and (3) assessment of degree of bother designated with the letter B. A scoring system was also developed. For interobserver reliability women were examined by two separate examiners using the FASS. For intraobserver reliability the FASS was repeated by the same examiner within 2 weeks. The interclass correlation coefficient (ICC) was also calculated to assess limits of agreements. Validity was assessed by comparing the FASS scores between symptomatic and asymptomatic women using the Mann-Whitney U test (p value <0.001).
RESULTS: A total of 177 women (98 symptomatic and 79 controls) were recruited. Intraobserver reliability had ICCs between 0.716 and 1. Interobserver reliability had ICCs between 0.795 and 0.909. Domain and total scores were significantly different between symptomatic and asymptomatic women (p < 0.001, Mann-Whitney U test). There was a good correlation between FASS P scores and POP-Q scores (rho 0.763, p < 0.001).
CONCLUSIONS: The FIGO prolapse assessment scoring system has good intraobserver and interobserver agreement and has demonstrated both content and construct validity.

Entities:  

Mesh:

Year:  2015        PMID: 25578870     DOI: 10.1007/s00192-014-2604-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  18 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system.

Authors:  Steven Swift; Sarah Morris; Vikki McKinnie; Robert Freeman; Eckhard Petri; Richard J Scotti; Peter Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-06

3.  Validation of the Pelvic Organ Prolapse Quantification Index (POP-Q-I): a novel interpretation of the POP-Q system for optimization of POP research.

Authors:  Nucélio Luiz de Barros Moreira Lemos; Antonio Pedro Flores Auge; Jacqueline Leme Lunardelli; Silvia da Silva Carramão; Ana Luiza Antunes Faria; Tsutomu Aoki
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-01-24

4.  Correlation of symptoms with location and severity of pelvic organ prolapse.

Authors:  R M Ellerkmann; G W Cundiff; C F Melick; M A Nihira; K Leffler; A E Bent
Journal:  Am J Obstet Gynecol       Date:  2001-12       Impact factor: 8.661

5.  Levator ani defect scores and pelvic organ prolapse: is there a threshold effect?

Authors:  Mitchell B Berger; Daniel M Morgan; John O DeLancey
Journal:  Int Urogynecol J       Date:  2014-05-01       Impact factor: 2.894

6.  Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system.

Authors:  A F Hall; J P Theofrastous; G W Cundiff; R L Harris; L F Hamilton; S E Swift; R C Bump
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

7.  Interobserver variation in the assessment of pelvic organ prolapse.

Authors:  W H Kobak; K Rosenberger; M D Walters
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

8.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.

Authors:  Steven Swift; Patrick Woodman; Amy O'Boyle; Margie Kahn; Michael Valley; Deirdre Bland; Wei Wang; Joe Schaffer
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

9.  The standardization of terminology for researchers in female pelvic floor disorders.

Authors:  A M Weber; P Abrams; L Brubaker; G Cundiff; G Davis; R R Dmochowski; J Fischer; T Hull; I Nygaard; A C Weidner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

Review 10.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

View more
  3 in total

1.  Use of botulinum toxin for chronic pelvic pain.

Authors:  Bhawana Purwar; Vik Khullar
Journal:  Womens Health (Lond)       Date:  2016-06-10

2.  Validation of the Sinhala translations of the Pelvic Floor Distress Inventory and the Pelvic Floor Impact Questionnaire in a Sri Lankan population.

Authors:  Vindya Wijesinghe; Piyankara Amaradivakara; Rameez Farukan
Journal:  Int Urogynecol J       Date:  2021-03-29       Impact factor: 2.894

3.  Transcultural translation and validation of the FIGO Assessment Scoring System (FASS) to Portuguese language.

Authors:  Ana Eliza Rios de Araújo Mathias; Márcia Silva de Oliveira; Carolina Mayumi Haruta; Fábia Maria de Lima; Kátia Cristina Lima de Petribú; Geraldo de Aguiar Cavalcanti; Steven E Swift; Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2018-10-24       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.